Functional significance of lipoprotein lipase HindIII polymorphism associated with the risk of coronary artery disease

Atherosclerosis

Volumn 200, Issue 1, 2008, Pages 102-108

  Chen, Qi ^a   Razzaghi, Hamid ^a   Demirci, F Yesim ^a   Kamboh, M Ilyas ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Coronary artery disease; Electrophoretic mobility shift assay; HindIII polymorphism; Lipoprotein lipase; Luciferase reporter gene assay

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LIPOPROTEIN LIPASE; LIPOPROTEIN LIPASE HINDIII; LUCIFERASE; TRANSCRIPTION FACTOR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL STRAIN COS1; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; GEL MOBILITY SHIFT ASSAY; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; HUMAN CELL; INTRON; LIPID METABOLISM; LPL GENE; MUTANT; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; TRIACYLGLYCEROL BLOOD LEVEL; WILD TYPE;

ANIMALS; CERCOPITHECUS AETHIOPS; CORONARY ARTERY DISEASE; COS CELLS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRONS; LIPOPROTEIN LIPASE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; SITE-SPECIFIC DNA-METHYLTRANSFERASE (ADENINE-SPECIFIC); TRANSCRIPTION FACTORS;

EID: 49749147556     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.12.011     Document Type: Article

References (46)

1. Goldberg I.J. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 37 (1996) 693-707
2. Mead J.R., Cryer A., and Ramji D.P. Lipoprotein lipase, a key role in atherosclerosis?. FEBS Lett 462 (1999) 1-6
3. Brunzell J.D., and Deeb S.S. Familial lipoprotein lipase deficiency, apo C-II deficiency, and hepatic lipase deficiency. In: Scriver C.R., Beundet A.L., Sly W.S., and Valle D. (Eds). The metabolic & molecular bases of inherited disease. 8th ed. (2001), McGraw-Hill, New York 2789-2816
4. Murthy V., Julien P., and Gagne C. Molecular pathobiology of the human lipoprotein lipase gene. Pharmacol Ther 70 (1996) 101-135
5. Lalouel J.-M., Wilson D.E., Iverius P.-H., and Lipoprotein. Lipase and hepatic triglyceride lipase: molecular and genetic aspects. Curr Opin Lipidol 3 (1992) 86-95
6. Razzaghi H., Aston C.E., Hamman R.F., and Kamboh M.I. Genetic screening of the lipoprotein lipase gene for mutations associated with high triglyceride/low HDL-cholesterol levels. Hum Genet 107 (2000) 257-267
7. Kuivenhoven J.A., Groenemeyer B.E., Boer J.M., et al. Ser447stop mutation in lipoprotein lipase is associated with elevated HDL cholesterol levels in normolipidemic males. Arterioscler Thromb Vasc Biol 17 (1997) 595-599
8. Morabia A., Cayanis E., Costanza M.C., et al. Association between lipoprotein lipase (LPL) gene and blood lipids: a common variant for a common trait?. Genet Epidemiol 24 (2003) 309-321
9. Vohl M.C., Lamarche B., Moorjani S., et al. The lipoprotein lipase HindIII polymorphism modulates plasma triglyceride levels in visceral obesity. Arterioscler Thromb Vasc Biol 15 (1995) 714-720
10. Mattu R.K., Needham E.W., Morgan R., et al. DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population. Arterioscler Thromb 14 (1994) 1090-1097
11. Gerdes C., Gerdes L.U., Hansen P.S., and Faergeman O. Polymorphisms in the lipoprotein lipase gene and their associations with plasma lipid concentrations in 40-year-old Danish men. Circulation 92 (1995) 1765-1769
12. Wittrup H.H., Tybjaerg-Hansen A., and Nordestgaard B.G. Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis. Circulation 99 (1999) 2901-2907
13. Hokanson J.E. Functional variants in the lipoprotein lipase gene and risk cardiovascular disease. Curr Opin Lipidol 10 (1999) 393-399
14. Taylor K.D., Scheuner M.T., Yang H., et al. Lipoprotein lipase locus and progression of atherosclerosis in coronary-artery bypass grafts. Genet Med 6 (2004) 481-486
15. Peacock R.E., Hamsten A., Nilsson-Ehle P., and Humphries S.E. Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. Atherosclerosis 97 (1992) 171-185
16. Fidani L., Hatzitolios A.I., Goulas A., Savopoulos C., Basayannis C., and Kotsis A. Cholesteryl ester transfer protein TaqI B and lipoprotein lipase Ser447Ter gene polymorphisms are not associated with ischaemic stroke in Greek patients. Neurosci Lett 384 (2005) 102-105
17. Spence J.D., Ban M.R., and Hegele R.A. Lipoprotein lipase (LPL) gene variation and progression of carotid artery plaque. Stroke 34 (2003) 1176-1180
18. Brousseau M.E., Goldkamp A.L., Collins D., et al. Polymorphisms in the gene encoding lipoprotein lipase in men with low HDL-C and coronary heart disease: the Veterans Affairs HDL Intervention Trial. J Lipid Res 45 (2004) 1885-1891
19. Mailly F., Tugrul Y., Reymer P.W., et al. A common variant in the gene for lipoprotein lipase (Asp9 → Asn). Functional implications and prevalence in normal and hyperlipidemic subjects. Arterioscler Thromb Vasc Biol 15 (1995) 468-478
20. Fisher R.M., Humphries S.E., and Talmud P.J. Common variation in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosis. Atherosclerosis 135 (1997) 145-159
21. Hata A., Robertson M., Emi M., and Lalouel J.M. Direct detection and automated sequencing of individual alleles after electrophoretic strand separation: identification of a common nonsense mutation in exon 9 of the human lipoprotein lipase gene. Nucleic Acids Res 18 (1990) 5407-5411
22. Rip J., Nierman M.C., Ross C.J., et al. Lipoprotein lipase S447X: a naturally occurring gain-of-function mutation. Arterioscler Thromb Vasc Biol 26 (2006) 1236-1245
23. Wittrup H.H., Nordestgaard B.G., Steffensen R., Jensen G., and Tybjaerg-Hansen A. Effect of gender on phenotypic expression of the S447X mutation in LPL: the Copenhagen City Heart Study. Atherosclerosis 165 (2002) 119-126
24. Enerbäck S., Ohlsson B.G., Samuelsson L., and Bjursell G. Characterization of the human lipoprotein lipase (LPL) promoter: evidence of two cis-regulatory regions, LP-alpha and LP-beta, of importance for the differentiation-linked induction of the LPL gene during adipogenesis. Mol Cell Biol 12 (1992) 4622-4633
25. Luedecking E.K., DeKosky S.T., Mehdi H., Ganguli M., and Kamboh M.I. Analysis of genetic polymorphisms in the transforming growth factor-beta1 gene and the risk of Alzheimer's disease. Hum Genet 106 (2000) 565-569
26. Quandt K., Frech K., Karas H., Wingender E., Werner T., and MatInd. MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 23 (1995) 4878-4884
27. Hall S., Chu G., Miller G., et al. A common mutation in the lipoprotein lipase gene promoter, -93 T/G, is associated with lower plasma triglyceride levels and increased promoter activity in vitro. Arterioscler Thromb Vasc Biol 17 (1997) 1969-1976
28. Previato L., Parrott C.L., Santamarina-Fojo S., and Brewer Jr. H.B. Transcriptional regulation of the human lipoprotein lipase gene in 3T3-L1adipocytes. J Biol Chem 266 (1991) 18958-18963
29. Aronow B., Lattier D., Silbiger R., et al. Evidence for a complex regulatory array in the first intron of the human adenosine deaminase gene. Genes Dev 3 (1989) 1384-13400
30. Celis L., Claessens F., Peeters B., Heyns W., Verhoeven G., and Rombauts W. Proteins interacting with an androgen-responsive unit in the C3(1) gene intron. Mol Cell Endocrinol 94 (1993) 165-172
31. Henkel G., and Brown M.A. PU.1 and GATA: components of a mast cell-specific interleukin 4 intronic enhancer. Proc Natl Acad Sci USA 91 (1994) 7737-7741
32. Wang L.G., Liu X.M., Li Z.R., Denstman S., and Bloch A. Differential binding of nuclear c-ets-1 protein to an intron I fragment of the c-myb gene in growth versus differentiation. Cell Growth Differ 5 (1994) 1243-1251
33. van Dijk T.B., Caldenhoven E., Raaijmakers J.A., Lammers J.W., Koenderman L., and de Groot R.P. The role of transcription factor PU.1 in the activity of the intronic enhancer of the eosinophil-derived neurotoxin (RNS2) gene. Blood 91 (1998) 2126-2132
34. Yajima I., Sato S., Kimura T., et al. An L1 element intronic insertion in the black-eyed white (Mitf[mi-bw]) gene: the loss of a single Mitf isoform responsible for the pigmentary defect and inner ear deafness. Hum Mol Genet 8 (1999) 1431-1441
35. Henderson H.E., Kastelein J.J., Zwinderman A.H., et al. Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteins. J Lipid Res 40 (1999) 735-743
36. Goodarzi M.O., Wong H., Quinones M.J., et al. The 3′ untranslated region of the lipoprotein lipase gene: haplotype structure and association with post-heparin plasma lipase activity. J Clin Endocrinol Metab 90 (2005) 4816-4823
37. Knudsen P., Murtomaki S., Antikainen M., et al. The Asn-291 → Ser and Ser-477 → Stop mutations of the lipoprotein lipase gene and their significance for lipid metabolism in patients with hypertriglyceridaemia. Eur J Clin Invest 27 (1997) 928-935
38. Garenc C., Perusse L., Gagnon J., et al. Linkage and association studies of the lipoprotein lipase gene with postheparin plasma lipase activities, body fat, and plasma lipid and lipoprotein concentrations: the HERITAGE Family Study. Metabolism 49 (2000) 432-439
39. Nierman M.C., Rip J., Kuivenhoven J.A., et al. Carriers of the frequent lipoprotein lipase S447X variant exhibit enhanced postprandial apoprotein B-48 clearance. Metabolism 54 (2005) 1499-1503
40. Nierman M.C., Prinsen B.H., Rip J., et al. Enhanced conversion of triglyceride-rich lipoproteins and increased low-density lipoprotein removal in LPLS447X carriers. Arterioscler Thromb Vasc Biol 25 (2005) 2410-2415
41. Yukht A., Davis R.C., Ong J.M., Ranganathan G., and Kern P.A. Regulation of lipoprotein lipase translation by epinephrine in 3T3-L1 cells. Importance of the 3′ untranslated region. J Clin Invest 96 (1995) 2438-2444
42. Ranganathan G., Vu D., and Kern P.A. Translational regulation of lipoprotein lipase by epinephrine involves a trans-acting binding protein interacting with the 3′ untranslated region. J Biol Chem 272 (1997) 2515-2519
43. Ranganathan G., Li C., and Kern P.A. The translational regulation of lipoprotein lipase in diabetic rats involves the 3′-untranslated region of the lipoprotein lipase mRNA. J Biol Chem 275 (2000) 40986-40991
44. Cirulli E.T., and Goldstein D.B. In vitro assays fail to predict in vivo effects of regulatory polymorphisms. Hum Mol Genet 16 (2007) 1931-1939
45. Mitchell J.R., Jacobsson A., Kirchgessner T.G., Schotz M.C., Cannon B., and Nedergaard J. Regulation of expression of the lipoprotein lipase gene in brown adipose tissue. Am J Physiol 263 (1992) E500-E506
46. Maheux P., Azhar S., Kern P.A., Chen Y.D., and Reuven G.M. Relationship between insulin-mediated glucose disposal and regulation of plasma and adipose tissue lipoprotein lipase. Diabetologia 40 (1997) 850-858